LCID
Lucid Group, Inc.
LCID has a slight edge over TLYS overall, supported by stronger valuation and stronger modeled upside.
TLYS
Tilly's, Inc.
TLYS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
TLYS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
TLYS's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
TLYS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.2x | $0.31 | -93% |
| Fair | 11x | $0.64 | -85% |
| Forward | 23x | $4.29 | — |
| Expensive | 40x | $2.38 | -45% |
| Current | 75x | $4.29 | — |
Historical ranges are pointers, not guarantees.
TLYS's PE is in its expensive range at 75x. If earnings grow as analysts expect, today's price would be 23x next year's earnings.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
TLYS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Returning to profit | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect TLYS to return to profit, with revenue holding steady. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
TLYS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.18 | +208% |
| Q3 2026 | $0.06 | +$1.57 |
| Q2 2026 | -$0.11 | +$1.51 |
| Q1 2026 | -$0.58 | +$0.96 |
| Q4 2025 | -$1.13 | +$0.64 |
| Q3 2025 | -$1.51 | -$0.14 |
| Q2 2025 | -$1.62 | -$0.21 |
| Q1 2025 | -$1.54 | -$0.38 |
| Q4 2024 | -$1.77 | -$1.30 |
TLYS has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over TLYS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
TLYS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $163.5M | +8.1% |
| Q2 2026 | $124.7M | +16% |
| Q1 2026 | $155.1M | +5.3% |
| Q4 2025 | $139.6M | -2.7% |
| Q3 2025 | $151.3M | -7.1% |
| Q2 2025 | $107.6M | -7.1% |
| Q1 2025 | $147.3M | -15% |
| Q4 2024 | $143.4M | -14% |
TLYS's revenue is recovering but still below its 2021 peak: $164M last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5% | +3.2 points |
| Q2 2026 | -6.5% | +15 points |
| Q1 2026 | 1.7% | +11 points |
| Q4 2025 | -1.4% | +8.4 points |
| Q3 2025 | 1.8% | +2.3 points |
| Q2 2025 | -21% | -3.1 points |
| Q1 2025 | -9.6% | -4.7 points |
| Q4 2024 | -9.8% | -8.3 points |
TLYS has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
TLYS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $20.9M | +56% |
| Q2 2026 | -$5.3M | +$4.4M |
| Q1 2026 | $7.3M | +$12.6M |
| Q4 2025 | -$11.7M | +$13.4M |
| Q3 2025 | $13.4M | +68% |
| Q2 2025 | -$9.6M | +$18.2M |
| Q1 2025 | -$5.4M | -1829% |
| Q4 2024 | -$25.1M | -$14.3M |
TLYS has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
TLYS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.5% | +1M shares |
| 1 year | +3% | +893K shares |
| 3 years | +4.5% | +1.3M shares |
| 5 years | +0.1% | +46K shares |
| Available history | +4.7% | +1.4M shares |
TLYS has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | $1.9M |
| Q3 2022 | $838,000 |
| Q2 2022 | $8.2M |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TLYS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.2x | Net Cash |
| Q2 2026 | -5.9x | Net Cash |
| Q2 2023 | -6.6x | Net Cash |
| Q1 2023 | -2.9x | Net Cash |
| Q3 2021 | -1.1x | Net Cash |
| Q2 2021 | -1.4x | Net Cash |
| Q1 2021 | -4.8x | Net Cash |
| Q3 2020 | -6.8x | Net Cash |
TLYS has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
TLYS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.4 | Neutral |
| Stochastic | 24.4 | Neutral |
TLYS's weekly RSI is 53 (neutral) and its Stochastic is 24 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
TLYS PE vs Consumer Cyclical Sector
| Metric | TLYS | Sector median | Relative |
|---|---|---|---|
| PE | 75x | 18x | 316% above |
| PE % | 89 | 47 | 42 pts above |
TLYS is trading at 75x earnings, a 316% premium to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
TLYS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.34 | 1.2% below |
| 20 week MA | $4.18 | 2.6% above |
| 50 week MA | $3.52 | 22% above |
| 100 week MA | $2.86 | 50% above |
| 200 week MA | $4.83 | 11% below |
TLYS has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
TLYS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.1 | $8.14 | -33% |
| 2021 | $8.14 | $15.3 | +88% |
| 2022 | $15.3 | $8.86 | -42% |
| 2023 | $8.86 | $7.54 | -15% |
| 2024 | $7.54 | $3.90 | -48% |
| 2025 | $3.90 | $1.83 | -53% |
| 2026 YTD | $1.83 | $4.29 | +134% |
TLYS has the edge over LCID on returns for 2026, with the stronger performance.